Prosecution Insights
Last updated: August 14, 2026
Application No. 18/430,680

METHODS FOR SUPPLEMENTING IRON, PROMOTING IRON ABSORPTION, AND/OR IMPROVING SKIN CONDITION BY USING SASKATOON BERRY EXTRACT

Final Rejection §103§112
Filed
Feb 02, 2024
Priority
May 22, 2023 — provisional 63/503,503 +1 more
Examiner
HOFFMAN, SUSAN COE
Art Unit
1655
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
TCI Co., Ltd.
OA Round
2 (Final)
54%
Grant Probability
Moderate
3-4
OA Rounds
5m
Est. Remaining
80%
With Interview

Examiner Intelligence

Grants 54% of resolved cases
54%
Career Allowance Rate
584 granted / 1078 resolved
-5.8% vs TC avg
Strong +26% interview lift
Without
With
+25.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
67 currently pending
Career history
1154
Total Applications
across all art units

Statute-Specific Performance

§101
10.4%
-29.6% vs TC avg
§103
35.6%
-4.4% vs TC avg
§102
15.1%
-24.9% vs TC avg
§112
27.7%
-12.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1078 resolved cases

Office Action

§103 §112
DETAILED ACTION 1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . 2. The amendment filed May 22, 2026 has been received and entered. The text of those sections of Title 35, U.S. Code, not included in this action can be found in a prior Office action. Any rejection set forth in a previous Office action that is not specifically set forth below is withdrawn. 3. Claims 1-15 are pending. Election/Restrictions 4. In the reply filed on February 12, 2026, applicant elected Group I, claims 1-7, without traverse. 5. Claims 8-15 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. 6. Claims 1-7 are examined on the merits. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. 7. Claims 1-7 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. The claims have been amended to state that the water used for the extraction of the Saskatoon berry is neutral. However, the specification and claims as originally filed do not discuss the pH or the purity of the water used as the extraction solvent. Thus, there is a lack of literal antecedent basis for this limitation. In addition, the pH of tap water can vary widely, generally a pH between 6.5 and 8.5 (see Christopher, page 1 (“What is the Best Ph Level for Drinking Water?” https://www.raynewater.com/blog/what-is-the-best-ph-level-for-drinking-water/) June 29, 2020). Thus, there is also a lack of inherent basis for the limitation of “neutral water” because the pH of water is not necessarily neutral, and only pure water would inherently be understood to have a neutral pH. Therefore, this new limitation introduces new matter into the disclosure of the application. Claim Rejections - 35 USC § 103 8. Claim(s) 1-7 are is/are rejected under 35 U.S.C. 103 as being unpatentable over “Saskatoon Berries” (https://web.archive.org/web/20220418160009/https://foodb.ca/reports/saskatoon_berry - internet archived version from April 18, 2022) in view of “Serviceberries” (https://www.uaf.edu/ces/publications/database/food/files/pdfs/FNH-00122-Serviceberries.pdf - January 2022) and Christopher (“What is the Best Ph Level for Drinking Water?” https://www.raynewater.com/blog/what-is-the-best-ph-level-for-drinking-water/) June 29, 2020). The “Saskatoon Berries” article teaches that Saskatoon berries are a good source of easily absorbed iron and are useful for treating anemia (see page 2). Thus, an artisan of ordinary skill would reasonably expect that Saskatoon berries could be administered to a subject in need (i.e. a subject with anemia) in order to promote the absorption of iron in that subject associated with the intake of the Saskatoon berries. This reasonable expectation of success would have motivated the artisan to administer Saskatoon berries to a subject in need thereof in order to promote the absorption of iron in the subject. The reference does not specifically teach that the Saskatoon berries are extracted with neutral water. However, the reference does teach that the Saskatoon berries can be administered as a juice (see page 1). The “Serviceberries” (synonymous with Saskatoon berries) article teaches that Saskatoon berry juice is made by extracting the berries with water (see page 1). Thus, it was known in the art at the time of the invention that Saskatoon berry juice is made by extracting the berries with water. Therefore, an artisan of ordinary skill would have reasonably expected that water extraction could be used to create the Saskatoon berry juice taught by the “Saskatoon Berries” article. This reasonable expectation of success would have motivated the artisan to modify the “Saskatoon Berries” article to include extraction of the berries with water. The references do not specifically teach extracting the berries using a neutral pH water, the ratios of water to berry, or the temperatures claimed by applicant. However, as discussed in MPEP section 2144.05(II)(A), “Generally, differences in concentration or temperature will not support the patentability of subject matter encompassed by the prior art unless there is evidence indicating such concentration or temperature is critical. ‘[W]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation.’ In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955).” Varying the extraction parameters such as temperature and solvent concentration is not considered to be inventive unless the concentrations and temperatures are demonstrated as critical. In this particular case, there is no evidence that the claimed concentrations or temperatures produces an unexpected result. In addition, Christopher teaches that the best pH for drinking water is 7 (see page 2). Therefore, an artisan of ordinary skill would reasonably expect that this pH would be the optimal pH to use when creating the Saskatoon berry water extract taught by the references. Thus, absent some demonstration of unexpected results from the claimed parameters, this optimization of extraction parameters would have been obvious before the effective filing date of applicant’s claimed invention. 9. No claims are allowed. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Susan Hoffman whose telephone number is (571)272-0963. The examiner can normally be reached M-Th 8:30am - 5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anand Desai can be reached at 571-272-0947. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SUSAN HOFFMAN/Primary Examiner, Art Unit 1655
Read full office action

Prosecution Timeline

Feb 02, 2024
Application Filed
Mar 09, 2026
Non-Final Rejection mailed — §103, §112
May 22, 2026
Response Filed
Jul 08, 2026
Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12691156
PREBIOTIC COMPOSITIONS AND METHOD FOR WEIGHT LOSS BY USING THE SAME
3y 0m to grant Granted Jul 28, 2026
Patent 12678460
Methods for Managing Adverse Events in Patients with Inflammation
3y 5m to grant Granted Jul 14, 2026
Patent 12667599
Pharmaceutical Composition or Health Functional Food for Prevention and Treatment of Obesity Containing Powder of Novel Hybrid Mushroom as Active Ingredient
3y 6m to grant Granted Jun 30, 2026
Patent 12661379
COMPOSITION COMPRISING CRICKET OR EXTRACT THEREOF FOR IMPROVING BOWEL MOVEMENT FUNCTION
3y 8m to grant Granted Jun 23, 2026
Patent 12637490
Method for the extraction of phycobiliproteins at high purity degree from cyanobacterial and/or algal biomasses
2y 11m to grant Granted May 26, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
54%
Grant Probability
80%
With Interview (+25.6%)
2y 11m (~5m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1078 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month